Cargando…
Do older patients truly benefit from advances in myeloma care?
Autores principales: | Gatt, Moshe E., Lebel, Eyal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230412/ https://www.ncbi.nlm.nih.gov/pubmed/36300777 http://dx.doi.org/10.3324/haematol.2022.281897 |
Ejemplares similares
-
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
por: Lebel, Eyal, et al.
Publicado: (2022) -
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
por: Gross Even-Zohar, Noa, et al.
Publicado: (2022) -
Do lectures truly kindle learning process?
por: Sheriff, Dhastagir Sultan
Publicado: (2010) -
Evidence-Based Medicine: Which Drugs Are Truly Contraindicated for Use in Older Adults?
por: Curtiss, Frederic R.
Publicado: (2005) -
Classical Swine Fever: A Truly Classical Swine Disease
por: Wang, Fun-In, et al.
Publicado: (2020)